Changes of retinal structure and visual function in patients with demyelinating transverse myelitis
- PMID: 35939134
- DOI: 10.1007/s10072-022-06315-1
Changes of retinal structure and visual function in patients with demyelinating transverse myelitis
Abstract
Purpose: To identify the retina-structural and visual-functional alterations in the patients with aquaporin-4 (AQP4)-IgG-positive neuromyelitis optica spectrum disorder (NMOSD), myelin oligodendrocyte glycoprotein-associated disease (MOGAD), and multiple sclerosis (MS) patients, all of whom had demyelinating transverse myelitis (TM) without optic neuritis (ON).
Methods: In this retrospective cross-sectional study, we reviewed the medical records of 97 patients, including 23 with AQP4-ON, 13 with AQP4-TM, 32 with MOG-ON, 3 with MOG-TM, 13 with MS-ON, and 13 with MS-TM. We measured the thickness of the retinal nerve fiber layer (RNFL) and the ganglion cell layer-inner plexiform layer (GCIPL) using optical coherence tomography to evaluate structural changes and compared these parameters with those of an age-matched healthy control. Functional outcomes were measured as visual acuity and mean deviation in visual field test.
Results: Mean RNFL and GCIPL thicknesses in all of the patients with TM were lower relative to the healthy control, while visual function was well preserved. Among the TM patients, RNFL thickness did not vary significantly among the groups, whereas GCIPL thickness in AQP4-TM and MS-TM was significantly lower than that in MOG-TM. All three TM groups showed significant mean RNFL reduction compared with the healthy control, whereas mean GCIPL thinning was evident only in AQP4-TM and MS-TM, not in MOG-TM.
Conclusion: Patients with demyelinating TM incur retina-microstructural damage that varies by specific disease entity. Damage is distinct in AQP4-IgG-positive NMOSD and MS, but it is not so severe as to cause functional damage.
Keywords: Aquaporin-4-IgG-positive neuromyelitis optica spectrum disorder (NMOSD); Multiple sclerosis; Myelin oligodendrocyte glycoprotein-associated disease (MOGAD); Optic neuritis; Transverse myelitis.
© 2022. Fondazione Società Italiana di Neurologia.
Similar articles
-
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 4: Afferent visual system damage after optic neuritis in MOG-IgG-seropositive versus AQP4-IgG-seropositive patients.J Neuroinflammation. 2016 Nov 1;13(1):282. doi: 10.1186/s12974-016-0720-6. J Neuroinflammation. 2016. PMID: 27802824 Free PMC article.
-
Retina thickness in clinically affected and unaffected eyes in patients with aquaporin-4 immunoglobulin G antibody seropositive neuromyelitis optica spectrum disorders: a systematic review and meta-analysis.J Neurol. 2023 Feb;270(2):759-768. doi: 10.1007/s00415-022-11482-4. Epub 2022 Nov 10. J Neurol. 2023. PMID: 36355186
-
Aquaporin-4 IgG seropositivity is associated with worse visual outcomes after optic neuritis than MOG-IgG seropositivity and multiple sclerosis, independent of macular ganglion cell layer thinning.Mult Scler. 2020 Oct;26(11):1360-1371. doi: 10.1177/1352458519864928. Epub 2019 Jul 31. Mult Scler. 2020. PMID: 31364464 Free PMC article.
-
Neuromyelitis optica spectrum disorders with antibodies to myelin oligodendrocyte glycoprotein or aquaporin-4: Clinical and paraclinical characteristics in Algerian patients.J Neurol Sci. 2017 Oct 15;381:240-244. doi: 10.1016/j.jns.2017.08.3254. Epub 2017 Aug 31. J Neurol Sci. 2017. PMID: 28991690
-
AQP4-IgG and MOG-IgG Related Optic Neuritis-Prevalence, Optical Coherence Tomography Findings, and Visual Outcomes: A Systematic Review and Meta-Analysis.Front Neurol. 2020 Oct 8;11:540156. doi: 10.3389/fneur.2020.540156. eCollection 2020. Front Neurol. 2020. PMID: 33132999 Free PMC article.
Cited by
-
Retinal optical coherence tomography measures in multiple sclerosis: a systematic review and meta-analysis.Ann Clin Transl Neurol. 2024 Sep;11(9):2236-2253. doi: 10.1002/acn3.52165. Epub 2024 Jul 28. Ann Clin Transl Neurol. 2024. PMID: 39073308 Free PMC article.
-
Retinal neurodegeneration in metabolic syndrome: a spectral optical coherence tomography study.Int J Ophthalmol. 2023 Feb 18;16(2):224-232. doi: 10.18240/ijo.2023.02.08. eCollection 2023. Int J Ophthalmol. 2023. PMID: 36816217 Free PMC article.
References
-
- Walsh RD, McClelland CM, Galetta SL (2012) The neuro-ophthalmology of multiple sclerosis. Future Neurol 7:679–700 - DOI
-
- Bennett J, De Seze J, Lana-Peixoto M, Palace J, Waldman A, Schippling S, Tenembaum S, Banwell B, Greenberg B, Levy M (2015) Neuromyelitis optica and multiple sclerosis: seeing differences through optical coherence tomography. Mult Scler J 21:678–688 - DOI
-
- Fazekas F, Barkhof F, Filippi M (1998) Unenhanced and enhanced magnetic resonance imaging in the diagnosis of multiple sclerosis. J Neurol Neurosurg Psychiatry 64(1):S2-5 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous